Apellis Pharmaceuticals
APLS
#3531
Rank
HK$22.42 B
Marketcap
HK$178.67
Share price
-0.11%
Change (1 day)
-59.03%
Change (1 year)

EPS for Apellis Pharmaceuticals (APLS)

EPS in 2023 (TTM): -HK$41.12

According to Apellis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$40.83. In 2022 the company made an earnings per share (EPS) of -HK$47.67 an increase over its 2021 EPS that were of -HK$68.82.

EPS history for Apellis Pharmaceuticals from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$41.12-13.73%
2022-HK$47.67-30.73%
2021-HK$68.8292.81%
2020-HK$35.69-11.73%
2019-HK$40.44123.18%
2018-HK$18.1227.08%
2017-HK$14.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.95-58.48%๐Ÿ‡บ๐Ÿ‡ธ USA